63
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      New Clonal Strain of Candida auris, Delhi, India : New Clonal Strain of Candida auris, Delhi, India

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A new clonal strain of Candida auris is an emerging etiologic agent of fungemia in Delhi, India. In 12 patients in 2 hospitals, it was resistant to fluconazole and genotypically distinct from isolates from South Korea and Japan, as revealed by M13 and amplified fragment length polymorphism typing.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: not found
          • Book Chapter: not found

          AMPLIFICATION AND DIRECT SEQUENCING OF FUNGAL RIBOSOMAL RNA GENES FOR PHYLOGENETICS

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

            A single strain of a novel ascomycetous yeast species belonging to the genus Candida was isolated from the external ear canal of an inpatient in a Japanese hospital. Analyses of the 26S rDNA D1/D2 domain, nuclear ribosomal DNA ITS region sequences, and chemotaxonomic studies indicated that this strain represents a new species with a close phylogenetic relationship to Candida ruelliae and Candida haemulonii in the Metschnikowiaceae clade. This strain grew well at 40 degrees C, but showed slow and weak growth at 42 degrees C. The taxonomic description of Candida auris sp. nov. is proposed (type strain JCM15448T= CBS10913T= DSM21092T).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.

              Background. Candida haemulonii, a yeast species that often exhibits antifungal resistance, rarely causes human infection. During 2004-2006, unusual yeast isolates with phenotypic similarity to C. haemulonii were recovered from 23 patients (8 patients with fungemia and 15 patients with chronic otitis media) in 5 hospitals in Korea. Methods. Isolates were characterized using D1/D2 domain and ITS gene sequencing, and the susceptibility of the isolates to 6 antifungal agents was tested in vitro. Results. Gene sequencing of the blood isolates confirmed C. haemulonii group I (in 1 patient) and Candida pseudohaemulonii (in 7 patients), whereas all isolates recovered from the ear were a novel species of which C. haemulonii is its closest relative. The minimum inhibitory concentration (MIC) ranges of amphotericin B, fluconazole, itraconazole, and voriconazole for all isolates were 0.5-32 microg/mL (MIC(50), 1 microg/mL), 2-128 microg/mL (MIC(50), 4 microg/mL), 0.125-4 microg/mL (MIC(50), 0.25 microg/mL), and 0.03-2 microg/mL (MIC(50), 0.06 microg/mL), respectively. All isolates were susceptible to caspofungin (MIC, 0.125-0.25 microg/mL) and micafungin (MIC, 0.03-0.06 microg/mL). All cases of fungemia occurred in patients with severe underlying diseases who had central venous catheters. Three patients developed breakthrough fungemia while receiving antifungal therapy, and amphotericin B therapeutic failure, which was associated with a high MIC of amphotericin B (32 microg/mL), was observed in 2 patients. Conclusions. Candida species that are closely related to C. haemulonii are emerging sources of infection in Korea. These species show variable patterns of susceptibility to amphotericin B and azole antifungal agents.
                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                Emerging Infect. Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                October 2013
                : 19
                : 10
                : 1670-1673
                Affiliations
                [1]Author affiliations: Vallabhbhai Patel Chest Institute, Delhi, India (A. Chowdhary, C. Sharma, K. Agarwal, A. Prakash, P.K. Singh, S. Kathuria, H.S. Randhawa); B.L. Kapur Memorial Hospital, New Delhi, India (S. Duggal, S. Jain); Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (F. Hagen, J.F. Meis); and Radboud University Nijmegen Medical Centre, Nijmegen (J.F. Meis)
                Author notes
                Address for correspondence: Anuradha Chowdhary, Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110 007, India; email: dranuradha@ 123456hotmail.com
                Article
                13-0393
                10.3201/eid1910.130393
                3810747
                24048006
                b3e3f3af-fb43-4049-875b-4d48b30f9c20
                History
                Categories
                Dispatch
                Dispatch
                Submitted: 3/16/2013
                Accepted: 5/09/2013
                DOI: http://dx.doi.org/10.3201/eid1910.130393
                13-0393 Dispatch
                Tables: 1
                Figures: 2
                Online: Technical Appendix (table)
                TOC title: New Clonal Strain of Candida auris, Delhi, India
                Article DOI: http://dx.doi.org/10.3201/eid1910.130393

                Infectious disease & Microbiology
                candida auris,fungemia,m13 fingerprinting,aflp,antifungal susceptibility,india,fungi,parasitic diseases

                Comments

                Comment on this article